Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study

被引:98
作者
Gibson, Peter R. [1 ,2 ]
Vaizey, Carolynne [3 ]
Black, Christopher M. [4 ,5 ]
Nicholls, Rebecca [6 ]
Weston, Adele R. [6 ]
Bampton, Peter [7 ]
Sparrow, Miles [1 ]
Lawrance, Ian C. [8 ]
Selby, Warwick S. [9 ,10 ]
Andrews, Jane M. [11 ,12 ]
Walsh, Alissa J. [13 ]
Hetzel, David J. [14 ]
Macrae, Finlay A. [15 ]
Moore, Gregory T. [2 ,16 ]
Weltman, Martin D. [17 ]
Leong, Rupert W. [18 ]
Fan, Tao [5 ]
机构
[1] Alfred Hosp, Melbourne, Vic 3004, Australia
[2] Monash Univ, Clayton, Vic, Australia
[3] St Marks Hosp, London EC1V 2PS, England
[4] St Johns Univ, Queens, NY USA
[5] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA
[6] OptumInsight, Sydney, NSW, Australia
[7] Flinders Private Hosp, Bedford Pk, SA, Australia
[8] Univ Western Australia, Sch Med & Pharmacol, Ctr Inflammatory Bowel Dis, Fremantle Hosp, Fremantle, WA, Australia
[9] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia
[10] Univ Sydney, Sydney, NSW 2006, Australia
[11] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, IBD Serv, Adelaide, SA 5000, Australia
[12] Univ Adelaide, Sch Med, Adelaide, SA, Australia
[13] St Vincents Hosp, Sydney, NSW 2010, Australia
[14] East Adelaide Med Ctr, Adelaide, SA, Australia
[15] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[16] Monash Med Ctr, Clayton, Vic 3168, Australia
[17] Univ Sydney, Nepean Hosp, Sydney, NSW 2006, Australia
[18] Concord Hosp, Sydney, NSW, Australia
关键词
Ulcerative colitis; Health care utilization; Disease severity; Quality of life; Utility; INFLAMMATORY-BOWEL-DISEASE; NATIONAL-SURVEY; CROHNS-DISEASE; PREVALENCE; INSTRUMENT; VALIDITY; UTILITY; EQ-5D;
D O I
10.1016/j.crohns.2013.11.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & aims: The burden of ulcerative colitis (UC) in relation to disease severity is not well documented. This study quantitatively evaluated the relationship between disease activity and quality of life (QoL), as well as health care utilization, cost, and work-related impairment associated with UC in an Australian population. Methods: A cross-sectional, noninterventional, observational study was performed in patients with a wide range of disease severity recruited during routine specialist consultations. Evaluations included the Assessment of Quality of Life-8-dimension (AQoL-8D), EuroQol 5-dimension, 5-level (EQ-5D-5L), the disease-specific Inflammatory Bowel Disease Questionnaire (IBDQ), and the Work Productivity and Activity Impairment (WPAI) instrument. The 3-item Partial Mayo Score was used to assess disease severity. Health care resource utilization was assessed by chart review and patient questionnaires. Results: In 175 patients, mean (SD) AQoL-8D and EQ-5D-5L scores were greater for patients in remission (0.80 [0.19] and 0.81 [0.18], respectively) than for patients with active disease (0.70 [0.20] and 0.72 [0.19], respectively, both Ps < 0.001). IBDQ correlated with both AQoL-8D (r = 0.73; P < 0.0001) and EQ-5D-5L (0.69; P < 0.0001). Mean 3-month UC-related health care cost per patient was AUD $2914 (SD = $3447 [mean for patients in remission = $1970; mild disease = $3736; moderate/severe disease = $4162]). Patients in remission had the least work and activity impairment. Conclusions: More severe UC disease was associated with poorer QoL. Substantial health care utilization, costs, and work productivity impairments were found in this sample of patients with UC. Moreover, greater disease activity was associated with greater health care costs and impairment in work productivity and daily activities. (C) 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 24 条
[1]  
Access Economics Pty Limited (Australia), 2007, EC COSTS CROHNS DIS
[2]  
AIHW (Australian Institute of Health and Welfare), 2012, HLTH SERV SER, V44
[3]  
Australian Medical Association, 2011, LIST MED SERV FEES
[4]   Direct medical cost of managing IBD patients: A Canadian population-based study [J].
Bernstein, Charles N. ;
Longobardi, Teresa ;
Finlayson, Greg ;
Blanchard, James F. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (08) :1498-1508
[5]   Factors affecting health related quality of life of patients with inflammatory bowel disease [J].
Casellas, F ;
López-Vivancos, J ;
Casado, A ;
Malagelada, JR .
QUALITY OF LIFE RESEARCH, 2002, 11 (08) :775-781
[6]   Systematic review: the costs of ulcerative colitis in Western countries [J].
Cohen, R. D. ;
Yu, A. P. ;
Wu, E. Q. ;
Xie, J. ;
Mulani, P. M. ;
Chao, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (07) :693-707
[7]   Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease [J].
Gibson, Peter R. ;
Weston, Adele R. ;
Shann, Amelia ;
Florin, Timothy H. J. ;
Lawrance, Ian C. ;
Macrae, Finlay A. ;
Radford-Smith, Graham .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) :1306-1312
[8]   Depression and Anxiety in Inflammatory Bowel Disease: A Review of Comorbidity and Management [J].
Graff, Lesley A. ;
Walker, John R. ;
Bernstein, Charles N. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (07) :1105-1118
[9]   Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey [J].
Gunnarsson, Candace ;
Chen, Jie ;
Rizzo, John A. ;
Ladapo, Joseph A. ;
Lofland, Jennifer H. .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (12) :3080-3091
[10]   Population norms for the AQoL derived from the 2007 Australian National Survey of Mental Health and Wellbeing [J].
Hawthorne, Graeme ;
Korn, Sam ;
Richardson, Jeff .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2013, 37 (01) :7-16